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Detection of Atrial Fibrillation Among Patients With Stroke Due to
Large or Small Vessel Disease: A Meta-Analysis
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Background-—Recent trials have demonstrated that extended cardiac monitoring increases the yield of paroxysmal atrial
ﬁbrillation (AF) detection in patients with cryptogenic stroke. The utility of extended cardiac monitoring is uncertain among patients
with stroke caused by small and large vessel disease. We conducted a meta-analysis to estimate the yield of AF detection in this
population.
Methods and Results-—We searched PubMed, Cochrane, and SCOPUS databases for studies on AF detection in stroke patients
and excluded studies restricted to patients with cryptogenic stroke or transient ischemic attack. We abstracted AF detection rates
for 3 populations grouped by stroke etiology: large vessel stroke, small vessel stroke, and stroke of undeﬁned etiology (a mixture of
cryptogenic, small vessel, large vessel, and other stroke etiologies). Our search yielded 30 studies (n=5687). AF detection rates
were similar in patients with large vessel (2.2%, 95% CI 0.3–5.5; n=830) and small vessel stroke (2.4%, 95% CI 0.4–6.1; n=520). No
studies had a monitoring duration longer than 7 days. The yield of AF detection in the undeﬁned stroke population was higher
(9.2%; 95% CI 7.1–11.5) compared to small vessel stroke (P=0.02) and large vessel stroke (P=0.02) populations.
Conclusions-—AF detection rate is similar in patients with small and large vessel strokes (2.2–2.4%). Because no studies reported
on extended monitoring (>7 days) in these stroke populations, we could not estimate the yield of AF detection with long-term
cardiac monitoring. Randomized controlled trials are needed to examine the utility of AF detection with long-term cardiac
monitoring (>7 days) in this patient population. ( J Am Heart Assoc. 2016;5:e004151 doi: 10.1161/JAHA.116.004151)
Key Words: cardiac monitoring • Holter monitoring • large vessel stroke • cardiac embolism • atrial ﬁbrillation
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S creening for atrial ﬁbrillation (AF) is of importance inpatients who have suffered a stroke, because the
detection of AF typically warrants a switch from antiplatelet
therapy to anticoagulation for secondary stroke prevention.1–5
Approximately 10% of patients with an ischemic stroke or
transient ischemic attack (TIA) will have new AF detected
during their hospital admission.6 However, AF can remain
undetected during the acute hospitalization, and randomized
controlled trials in cryptogenic stroke patients have shown
increased rates of AF detection with long-term ambulatory
cardiac monitoring.7,8 Most studies assessing long-term
cardiac monitoring after ischemic stroke are conducted in
the subset of patients with cryptogenic stroke. In this
population, the yield of AF detection is 10% per year.8 The
prevalence of AF in patients with small or large vessel strokes
is far less studied. We conducted a meta-analysis to estimate
the yield of AF detection in patients with stroke due to small
and large vessel disease and in stroke patients in whom
stroke etiology was not deﬁned (a mixture of cryptogenic,
small vessel, large vessel, and other stroke etiologies).
Methods
Search Strategy and Inclusion Criteria
We followed PRISMA guidelines for systematic reviews and
meta-analyses9 and searched PubMed, Cochrane, and
SCOPUS databases for cardiac monitoring studies on
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detection of AF in stroke patients according to a prespeciﬁed
protocol. We used the following search terms: “Stroke” AND
any of “atrial ﬁbrillation”, “cardiac embolism”, “cardio-
embolism”, “cardiac monitoring”, “telemetry”, “Holter”, “loop
recording”. We searched articles from January 1990 until June
30, 2015. References of eligible clinical studies were
examined to include any missed relevant articles. Search
strategy and progress is detailed in Figure 1.
We included studies with all types of long-term cardiac
monitoring and did not exclude studies based on monitoring
duration, AF length deﬁnition, or interval between index event
and initiation of monitoring. Studies were excluded if they
were not in English, used standard 12-lead (10 s) ECG as the
only detection method, included patients with previously
known AF, were limited to patients with TIA, or were limited to
cryptogenic stroke patients.
For each included study, data were extracted by the ﬁrst
author. The study type (prospective versus retrospective and
monocenter versus multicenter), study population, monitoring
type, monitoring duration, and monitoring interval were
recorded. In the studies that deﬁned stroke etiology, the
means of classiﬁcation was recorded. If multiple, sequential
AF detection methods were used, the total yield of all the
individual methods was extracted. Since some studies
reported rate of AF without specifying the yield per technique
(standard ECG or long-term monitoring), we performed a
sensitivity analysis on studies that explicitly stated the yield of
long-term monitoring only. We adopted the deﬁnitions for AF
that were used in the individual studies.
Studies were grouped according to whether or not a
presumed stroke etiology was speciﬁed. We determined
detection rates of AF in patients classiﬁed by stroke etiology:
small vessel etiology, large vessel etiology, and undeﬁned
etiology (the latter included studies inwhich stroke etiologywas
not investigated or not reported on; these studies therefore
include a mix of cryptogenic, small vessel, large vessel, and
Search terms: “Stroke” AND (“Atrial ϐibrillation” 
OR ““cardiac embolism” OR “cardio-embolism” 
OR “cardiac monitoring” OR “telemetry” OR 
“Holter” OR “loop recording”)
Limits: English language, full text available, 
publication between 01/1990 and 07/2015.
Potentially relevant citations from PUBMED, 
COCHRANE and SCOPUS databases (n = 
25.385)
Articles retrieved for detailed evaluation 
(n = 4.332)
Articles excluded based on 
title and/or abstract 
(n = 21.095)
Excluded with reason: 
- review/meta-analysis (n = 3028)
- case report (n = 538)
- editorials & correspondence (n = 314)
- method studies/technology assessments 
(n = 239)
- guidelines (n = 78)
- duplicate studies (n = 17)
- only reporting on cryptogenic stroke (n = 
67)
- ECG as only detection method detection 
(n = 15)
Snowball methods: articles retrieved from 
2 reviews (n = 5)
Duplicate patient cohort (n = 1)
Full-text articles included in 
meta-analysis (n = 31)
Articles included in meta-
analysis (n = 30)
Figure 1. Search strategy and progress.
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other stroke etiologies). This meta-analysis was registered with
PROSPERO (registration number CRD42016033999). Approval
by the institutional review committee and subject informed
consent were waived.
Statistical Methods
Summary estimates of the percentage of patients with AF for
each subgroup (small vessel disease, large vessel disease,
and patients with undeﬁned stroke etiology) were calculated
using a random-effects approach.10 Individual study estimates
were the arcsine-transformed proportions, to account for
studies with zero events.11 Heterogeneity between studies
was quantiﬁed by the I2 statistic and tested by Cochran’s chi-
square test. A random-effects meta-regression was used to
compare the percentages of AF detection between groups
(small vessel stroke versus large vessel stroke versus
undeﬁned etiology). Meta-regression was also used to explore
to which extent study type, study population (stroke only
versus stroke and TIA), and monitoring duration (more than
versus less or equal to 24 hours) accounted for between-
study heterogeneity. The analysis was performed for each of
these study characteristics separately, with group added as a
ﬁxed effect. Tukey adjustments were used for post-hoc
pairwise comparisons. All analyses were performed with SAS
software (version 9.2 of the SAS System for Windows,
Copyright © 2002 SAS Institute Inc), using the procedure
PROC MIXED and self-written code.
Results
The search yielded 25 385 results (Figure 1). Themeta-analysis
included 30 studies6,12–40 comprising 5687 patients (study
characteristics, Tables 1 and 2). All included studies were
cohort studies. Twenty-one studies had a prospective design*
and the other 10 were retrospective studies with consecutive
enrollment of stroke patients.12,13,15,23,26,31–34,38 Stroke etiol-
ogy of included patients was not deﬁned in 21 studies (4337
patients, Table 2).6,21–40 The 9 remaining studies categorized
stroke patients according to stroke subtype (1350 patients with
small or large vessel stroke, Table 1).12–20 Of those, 5 used the
Trial of ORG 10172 in acute stroke treatment (TOAST)
classiﬁcation for allocation of stroke subtypes.12,16–18,20,41
The other 4 used expert opinion (n=1) or did not specify the
classiﬁcation method (n=3).13–15,19
Median monitoring duration ranged from 22.6 hours32 to
504 hours24 (Tables 1 and 2). Median monitoring duration in
cohorts reporting on patients classiﬁed according to stroke
etiology (n=1350) was 24 hours (interquartile range: 24–73).
In the 21 studies (n=4337) in which stroke etiology was not
reported, the median monitoring duration was 55 hours
(interquartile range: 24–75.5). Twelve studies reported an
average monitoring duration of 24 hours or less.† Only 2
studies monitored patients for at least 7 days.24,29 None of
these studies speciﬁed the stroke etiology. The interval
between admission of a patient and the start of monitoring
was not always speciﬁed and differed greatly between
individual studies, ranging from initiation at admission33,39,40
to more than 2 to 3 weeks post stroke21 (Tables 1 and 2).
The deﬁnition of AF differed between studies (Tables 1 and 2).
The mean AF detection yield was 2.4% (95% CI 0.4–6.1;
Figure 2) in patients with small vessel stroke (n=520) and
2.2% (95% CI 0.3–5.5; Figure 3) in patients with large vessel
Table 1. Study Characteristics: Stroke Categorized According to Subtype
Study Study Type
Study
Population n % AF Monitoring Type
Interval Admission
to Monitoring
Monitoring Duration:
Where Given: Median (SD)
AF Length
Deﬁnition
Bansil and Karim, 200412 Retro, mono (1) 56 3.6 Telemetry N/S 24 h N/S
Shafqat et al, 200413 Retro, mono (2) 42 0 Holter monitoring N/S 22.8 h (4) N/S
Tagawa et al, 200714 Pro, mono (2) 190 6.8 Holter monitoring ≤2 to 7 days 24 h Any
Lazzaro et al, 201215 Retro, mono (2) 28 0 Telemetry
Holter monitoring
N/S 73.4 h
29.8 h
N/S
Shibazaki et al, 201216 Pro, mono (2) 194 0 Telemetry+Holter
monitoring
N/S 24 h N/S
Grond et al, 201317 Pro, multi (2) 564 2.5 Holter monitoring 24 73 h (range 1–134 days) >30 s
Wohlfahrt et al, 201418 Pro, mono (2) 106 17 Holter monitoring N/S 160.8 h (IQR 105; 6–158 h) >30 s
Maruyama et al, 201419 Pro, mono (2) 148 2 Holter monitoring N/S 24 h N/S
Thakkar et al, 201420 Pro, mono (2) 22 0 Holter monitoring <7 days 24 h N/S
Symbols: %AF, proportion of patients in whom AF was detected; (1), ischemic stroke and transient ischemic attack; (2), ischemic stroke. AF indicates atrial ﬁlbrillation; Mono, monocenter;
multi, multicenter; n, number of patients in study; N/S, not speciﬁed; pro, prospective; retro, retrospective.
*References 6, 14, 16–22, 24, 25, 27–30, 35–37, 39, 40.
†References 13, 14, 19, 20, 25, 26, 28, 31, 32, 36, 37, 39.
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disease (n=830; P for difference=0.99). The mean yield of AF
detection in studies that did not deﬁne stroke etiology
(n=4337) was 9.2% (95% CI 7.1–11.5; Figure 4). This was
higher compared to patients with small vessel stroke (P=0.02)
and patients with large vessel stroke (P=0.02).
Most studies either excluded patients with AF diagnosed
on ECG or speciﬁed the number of patients who were
diagnosed with AF based on ECG results. Six studies did not
distinguish the proportion of patients diagnosed with AF on
admission ECG.12,19,26,27,32,35 We performed a sensitivity
analysis after exclusion of those 6 studies to assess AF
detection yield in the subgroup of studies reporting exclu-
sively on long-term cardiac monitoring. In this sensitivity
analysis, the mean rate of AF detection was identical in
patients with small vessel stroke (2.0%; 95% CI 0.0–7.5) and
large vessel stroke (2.0%; 95% CI 0.0–7.9). In patients with
undeﬁned stroke etiology, the mean AF detection rate
trended higher (9.3%; 95% CI 6.4–12.9), compared to patients
with small vessel stroke (P=0.06) and large vessel stroke
(P=0.08).
We identiﬁed considerable between-study heterogeneity,
with an I2 of 75% for studies reporting on small vessel stroke,
Table 2. Study Characteristics: Stroke of Undeﬁned Etiology
Study Study Type
Study
Population n % AF Type of Monitoring
Monitoring
Interval
Monitoring Duration
Where Given:
Median (SD)
AF Length
Deﬁnition
Schuchert et al, 199921 Pro, mono (2) 82 6.1 Holter monitoring <21 days 72 h >1 minute
Jabaudon et al, 200422 Pro, mono (1)* 139 8.6 Holter monitoring+
7 day
event recorder
26 h 75 h N/S
Vandenbroucke and Thijs,
200423
Retro, mono (1)† 114 6.1 Holter monitoring N/S 72 h (IQR 48–98) N/S
Wallmann et al, 200724 Pro, mono (2)‡ 127 14.2 397 day event
recorder
N/S 21 days ≥30 s
Douen et al, 200825 Pro, mono (2) 123 7.3 Holter monitoring 3.7 days 24 h N/S
Yu et al, 200926 Retro, mono (2) 96 9.4 Holter monitoring N/S 24 h N/S
Vivanco Hidalgo et al, 200927 Pro, mono (2) 465 7.1 Telemetry N/S 55 h (36) Any
Schaer et al, 200928 Pro, mono (2) 147 0 Holter monitoring N/S 24 h >30 s
Stahrenberg et al, 201029 Pro, mono (2) 220 12.7 Holter monitoring N/S 7 days >30 s
Kallm€unzer et al, 201230 Pro, mono (2) 245 7.3 Serial ECG+Telemetry N/S 75.5 h (IQR 64–86) N/S
Dogan et al, 201231 Retro, mono (2) 400 10 Holter monitoring N/S 24 h >30 s
Sobocinski et al, 201232 Retro, multi (2) 249 6.8 Holter+intermittent ECG <24 h 22.6 h N/S
Sposato et al, 201233 Retro, mono (2) 110 18.2 Telemetry 0 h 5 days (IQR 3–12) Any
Atmuri et al, 201234 Retro, mono (2) 129 9.3 Holter monitoring N/S N/S N/S
Rizos et al, 20126 Pro, mono (2) 496 13.7 Holter monitoring+
Telemetry
7.5 h
(range 3.5–25)
64 h (range
43–89.8)
>30 s
Gonzalez Toledo et al, 201335 Pro, mono (2) 211 10.9 Telemetry N/S ≥72 h N/S
Higgins et al, 201336 Pro, multi (2) 100 25 Holter (n=50)+Event
recorder (n=50)
<7 days 24 h Any
Beaulieu-Boire et al, 201337 Pro, mono (2) 284 24 Holter monitoring <7 days 24 h N/S
Prefasi et al, 201338 Retro, mono (2)§ 147 2.7 Telemetry+Holter N/S 96 h Any
Fernandez et al, 201439 Pro, mono (2) 149 12.8 Event recorder 0 h 24 h Any
Suissa et al, 201440 Pro, mono (2) 304 13.8 Telemetry+Holter 0 h 5.3 days
(range 3.4–9.7)
>30 s
Symbols: %AF, proportion of patients in whom AF was detected; (1), ischemic stroke and transient ischemic attack; (2), ischemic stroke. AF indicates atrial ﬁbrillation; IQR, interquartile
range; mono, monocenter; multi, multicenter; n, number of patients in study; N/S, not speciﬁed; pro, prospective; retro, retrospective.
*Only prior permanent AF excluded.
†With conﬁrmed diffusion-weighted imaging lesion, prior AF documented 2 years prior to admission excluded.
‡AF during hospitalization or on 24-h Holter excluded.
§Patients over 50 years old excluded.
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an I2 of 79% for studies on large vessel stroke, and an I2 of
84% in undeﬁned stroke studies. We therefore performed an
exploratory analysis for factors accountable for this between-
study heterogeneity. Study type (prospective versus
retrospective and monocenter versus multicenter) did not
inﬂuence AF detection yield. Only 3.1% of heterogeneity was
explained by the difference in detection rates between
prospective and retrospective studies (P=0.24) and 1.5% by
Figure 2. Proportion of small vessel stroke patients diagnosed with atrial ﬁbrillation. AF indicates atrial ﬁbrillation.
Figure 3. Proportion of large vessel stroke patients diagnosed with atrial ﬁbrillation. AF indicates atrial ﬁbrillation.
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the difference in yield between monocenter and multicenter
studies (P=0.45). Monitoring type (Holter monitoring versus
other) explained only 2.8% of the heterogeneity (P=0.33).
Monitoring duration, dichotomized in less or more than
24 hours, accounted for 7.3% of the between-study hetero-
geneity with a trend toward higher rates with longer
monitoring duration (3.2% versus 5.5%; P=0.16). AF length
deﬁnition (undeﬁned or shorter than 30 s versus longer or
equal to 30 s) explained 5.1% of the heterogeneity between
studies with a nonsigniﬁcant trend towards higher detection
yield in studies deﬁning AF for a duration of at least 30 s
(3.5% versus 6.1%, P=0.13). Inclusion of TIA patients in the
study population explained 29.4% of the between-study
heterogeneity. The mean AF detection rate in studies
including stroke patients was 1.6% compared to 5.2% in
studies including stroke and TIA patients (P=0.01). Correction
for inclusion of TIA patients in the study population did not
alter the result that the AF detection rate is higher in patients
with undeﬁned stroke etiology compared to patients with
small vessel stroke (P=0.004) and large vessel stroke
(P=0.002).
Discussion
This meta-analysis demonstrates that the yield of AF detec-
tion with relatively short duration ambulatory cardiac moni-
toring is 2% to 2.5% in patients with small and large vessel
disease strokes. In studies that did not deﬁne stroke etiology
(a mixture of cryptogenic, small vessel, large vessel, and other
stroke etiologies), the rate of AF detection was 9.3%, which is
similar to previously documented rates of AF detection in
cryptogenic stroke patients.7,8
Many observational studies and 2 randomized trials have
been published on long-term cardiac monitoring of crypto-
genic stroke patients with monitoring duration of 30 days and
more.7,8 The results show a relationship between monitoring
duration and the rate of AF identiﬁcation. This relationship
was most strikingly demonstrated in the Cryptogenic stroke
and underlying AF (CRYSTAL AF) trial, in which a subgroup of
patients underwent continuous cardiac monitoring for a
period of 3 years.8 Based on the ﬁndings on cardiac
monitoring in cryptogenic stroke patients, long-term monitor-
ing is recommended for patients with stroke of unknown
etiology. In our meta-analysis of patients with stroke due to
large or small vessel disease, the median duration of
monitoring was only 24 hours and we did not identify any
studies that reported on extended monitoring (>7 days) in
this population. Due to this lack of data, no recommendation
can be made on cardiac monitoring duration in this subgroup
of patients.
The etiologic and therapeutic implications of AF detection
in patients with large or small vessel disease stroke are not
ﬁrmly established. Especially in patients with large vessel
disease as a potential cause of the ischemic stroke, qualifying
Figure 4. Proportion of stroke patients of undeﬁned etiology diagnosed with atrial ﬁbrillation. AF indicates atrial ﬁbrillation.
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AF as incidental versus pathological can be rather compli-
cated. Although in some patients the detection of AF leads to
a change in the presumed stroke etiology, in many others AF
detection could be considered incidental and would therefore
not lead to a change in the etiological classiﬁcation.
Furthermore, while all guidelines recommend anticoagulation
over antiplatelet therapy in patients with AF and a history of
stroke, the beneﬁt of anticoagulation has never been directly
demonstrated in patients with presumed small or large vessel
disease stroke and a coinciding ﬁnding of paroxysmal AF on
long-term ambulatory cardiac monitoring. It is possible that
the relative beneﬁt of anticoagulation is reduced in this
population and could differ between patients with small
versus large vessel disease. It is also possible that the
baseline risk of recurrent stroke is lower in this population
than would be expected based on the patients’ risk scores
(CHADS2 or CHA2DS2–VASc). This would translate into a
decrease of the absolute beneﬁt of anticoagulation even if the
relative beneﬁt were the same.
This study has several limitations. First, although this is the
largest study of AF detection in patients with large and small
vessel disease strokes, we could still have lacked power to
detect a signiﬁcant difference in AF detection rates between
patients with small and large vessel disease strokes. Second,
considerable heterogeneity between individual studies was
revealed. An exploratory analysis failed to detect important
variables explaining the heterogeneity in AF detection rates.
“Study population” deﬁned as inclusion/exclusion of TIA
patients was the only signiﬁcant factor in the meta-regression,
explaining 29% of the between-study heterogeneity. However,
the higher detection yield upon inclusion of TIA patients is
unintuitive, and the difference in study population did not
explain the obtained differences in AF detection yield between
studies where stroke etiology was undeﬁned compared to
studies limited to large or small vessel stroke patients. Other
variables that were either not assessed in the study popula-
tions or were too variable among studies to be included in the
analysis (eg, type of monitoring device) may account for some
of the unexplained heterogeneity. Third, since monitoring
duration in most studies was relatively short, no suggestion
on optimal monitoring duration can be derived from these
data. For that reason, we were also not able to calculate the
cost-effectiveness of long-term cardiac monitoring in patients
with small or large vessel stroke.
In summary, the AF detection rate with long-term cardiac
monitoring among patients with small and large vessel
disease stroke is 2% to 2.5%. However, these data are based
on only 9 studies, none of which used monitoring durations
that exceeded 7 days. Compared to cryptogenic stroke
populations, data on long-term cardiac monitoring are there-
fore very limited in patients with small and large vessel
strokes and clinical trials are needed to determine the yield of
AF detection with long-term monitoring in this population.
These trials may also give some insight into the rate of stroke
recurrence, the effect of anticoagulation on stroke recurrence
among patients with presumed small or large vessel disease
stroke who are diagnosed with AF, and the cost-effectiveness
of long-term cardiac monitoring in this speciﬁc population.
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